scholarly journals Combination of type 2 diabetes mellitus and cardiovascular pathology: structure, features of clinical profile and change of metabolism

2015 ◽  
Vol 0 (4(52)) ◽  
pp. 31-36
Author(s):  
І. В. Чернявська
2019 ◽  
Vol 23 (3) ◽  
pp. 293
Author(s):  
Indira Maisnam ◽  
Mainak Banerjee ◽  
Manidipa Majumdar ◽  
PrabirK Kundu ◽  
ApurbaK Mukherjee

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1472-P
Author(s):  
KENNETH CUSI ◽  
MICHAEL RODEN ◽  
ALFRED S. BARRITT ◽  
ROBERTO J. FIRPI ◽  
VIRGINIA CLARK ◽  
...  

2020 ◽  
Vol 22 (12) ◽  
pp. 57-62
Author(s):  
Irina I. Kochergina ◽  

The article presents data on the prevalence of diabetes and prediabetes; the high compatibility of diabetes mellitus and cardiovascular pathology; high mortality among patients with diabetes mellitus and coronary heart disease, in the presence of both acute and chronic cardiovascular complications; on the important role of glucose- and lipotoxicity in the progression of carbohydrate metabolism from prediabetes to type 2 diabetes mellitus, the role of hyperglycemia in the deve-lopment of insulin resistance, atherosclerosis, hypertension, liver, kidney, endothelial dysfunction, the role of hyper- and hypoglycemia in the development of acute vascular complications – myocardial infarction, stroke, gangrene of the lower extremities; on the protective role of adiponectin – a predictor of type 2 diabetes mellitus, on the importance of glycemic control for the timely detection of early disorders of carbohydrate metabolism – impaired glucose tolerance and impaired fasting glucose; on the role of metformin in the prevention of progression of prediabetes to type 2 diabetes and cardiac pathology; on the gluco- and cardioprotective role of modern sugar-lowering drugs.


2018 ◽  
Vol 5 (2) ◽  
pp. 140-144
Author(s):  
Neelima Chafekar ◽  
Jitendra Kodilkar ◽  
Parth Deogaonkar ◽  
Maansi Gujarathi ◽  
◽  
...  

2021 ◽  
Vol 10 (1) ◽  
pp. 29-32
Author(s):  
Sanjay Shrestha ◽  
Rajesh Kumar Mandal ◽  
Kijan Maharjan

Background and Aims: Microalbuminuria is an early marker of diabetic nephropathy, which accounts for a significant reduction in life expectancy of diabetic patients. Timely detection of microalbuminuria facilitates appropriate preventive and therapeutic approaches to minimize risks. The aim of this study is to determine the prevalence and association of microalbuminuria with clinical profile and complications of type 2 diabetes mellitus. Methods: This study was a descriptive, cross sectional study involving 100 diabetic subjects between July 2018 to January 2019 at Bir Hospital. Microalbuminuria (mg/dl) was defined as spot urine albumin to creatinine ratio of 30-300 mg/g (Kidney Disease Improving Global Outcomes guidelines) in a single spot urine sample. Statistical analysis was done using Statistical package for the social sciences version 20. Results: Microalbuminuria was found in 35% of the sample and the rate was significantly higher among males (P =0.027). Microalbuminuria was significantly related to Body mass index (P = 0.018), duration of diabetes (P =0.000), retinopathy (P = 0.000) and stroke (P = 0.043). No statistically significant relation was found between microalbuminuria and age (P = 0.366), hypertension (P = 0.208), HbA1c (P = 0.098), dyslipidemia (P = 0.171) and ischemic heart disease (P = 0.651). Conclusions: This study shows high prevalence of microalbuminuria in Nepalese Type 2 diabetes mellitus. Screening for microalbuminuria should be done for all the type 2 diabetes mellitus patients for early detection and management of complications of diabetes mellitus.  


2020 ◽  
Vol 8 (3) ◽  
pp. 845-849
Author(s):  
Athira Kalangadan ◽  
Shifa Puthiyamadathil ◽  
Snana Koottat ◽  
Shejila Chillakunnel Hussain Rawther ◽  
Assuma Beevi T M

Sign in / Sign up

Export Citation Format

Share Document